Early-onset pancreatic cancer: a population-based study using the SEER registry
Authors:
Open Access
- 3 August 2019
- journal article
- research article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 404 (5) , 565-571
Abstract
Background Early-onset pancreatic cancer (< 50 years, EOPC) is uncommon and limited data exist on clinical presentation and long-term survival. The aim of this study was to compare outcomes between patients with EOPC and those with later-onset pancreatic cancer (≥ 50 years, LOPC) using a large population-based cohort. Methods The Surveillance, Epidemiology, and End Results (SEER) database was queried to identify patients with a microscopically confirmed pancreatic ductal adenocarcinoma for the period 2004 to 2016. Propensity score matching was used to compare overall survival (OS) and cancer-specific survival (CSS) between patients with EOPC and LOPC. The EOPC and LOPC patients were paired 1:1 on propensity scores based on gender, tumor location, tumor size, AJCC stage, and treatment details. Results The overall cohort included 72,906 patients with pancreatic ductal adenocarcinoma, including 4523 patients with EOPC (6.2%). EOPC patients were diagnosed at a more advanced AJCC stage (p < 0.001) compared with LOPC patients and received significantly more treatment, including surgery (p < 0.001), radiation (p < 0.001), and chemotherapy (p < 0.001). Following propensity score matching, 3172 EOPC patients were matched to 3172 LOPC patients, alleviating any covariate differences between the groups. The matched analysis showed that EOPC was associated with poorer 5-year OS (6.1% vs 8.6%, p = 0.003) and 5-year CSS (6.7% vs 9.7%, p < 0.001). In multivariable Cox regression analysis, EOPC remained significantly associated with adverse OS and CSS. Subgroup analyses showed that EOPC was associated with adverse 5-year OS (17.7% vs 26.9%, p < 0.001) and 5-year CSS (18.9% vs 29.7%, p < 0.001) in operated patients. After multivariable analysis, EOPC remained significantly associated with OS and CSS. For patients that did not undergo surgery, the OS and CSS remained dismal without any significant differences between the groups. Conclusion To our knowledge, this is the largest study to compare the outcome of EOPC vs LOPC, as well as the first to use propensity score matching methodology for this purpose. The findings demonstrate that EOPC is diagnosed at a later stage and the matched survival analysis demonstrated reduced OS and CSS. We suggest that pancreatic cancer in young patients may have a unique tumor biology, which may be of importance for risk stratification and patient counseling.Keywords
Funding Information
- Lund University
This publication has 24 references indexed in Scilit:
- The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004–2009PLOS ONE, 2013
- Clinical Characteristics of Early Onset Pancreatic AdenocarcinomaPancreas, 2011
- Breast cancer in young womenBreast Cancer Research, 2010
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic CancerClinical Cancer Research, 2009
- Pancreatic adenocarcinoma in a young patient population—12‐year experience at Memorial Sloan Kettering Cancer CenterJournal of Surgical Oncology, 2009
- Impact of aging on the biology of breast cancerCritical Reviews in Oncology/Hematology, 2008
- Early Onset Pancreatic Cancer: Evidence of a Major Role for Smoking and Genetic FactorsCancer Epidemiology, Biomarkers & Prevention, 2007
- An epidemiologic study of early onset lung cancerLung Cancer, 2006
- Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40Journal of Clinical Pathology, 2006
- Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 yearsCancer, 2003